Results 191 to 200 of about 2,285,924 (374)

From Trials to Practice: A 2025 Review of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel Efficacy Across Clinical Studies and Real‐World Evidence

European Journal of Haematology, EarlyView.
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez, Sakditad Saowapa, Andrea Ortiz Maldonado, Chanakarn Kanitthamniyom, Diego Olavarria Bernal, Lukman Tijani   +5 more
wiley   +1 more source

Proposals for the classification of the myelodysplastic syndromes

British Journal of Haematology, 1982
J. Bennett, D. Catovsky, M. Daniel, G. Flandrin, D. Galton, H. Gralnick, H. Gralnick, C. Sultan   +7 more
semanticscholar   +1 more source

Real‐world efficacy and safety of immunochemotherapy in cold agglutinin‐mediated autoimmune haemolytic anaemia

British Journal of Haematology, EarlyView.
Femke V. M. Mulder, Anne‐Marie L. Becking, Sophie J. Bernelot Moens, Marit Jalink, Dorothea Evers, Liane te Boome, Anouk Breedijk, Jolanda Droogendijk, René van der Griend, Koen de Heer, Anja B. U. Mäkelburg, Caroline M. P. W. Mandigers, Laurens Nieuwenhuizen, Rimke Oostvogels, J. F. M. (Hans) Pruijt, Josien Regelink, Josien Rozenberg, Leonie Strobbe, Fleur M. van der Valk, Birgit I. Lissenberg‐Witte, Josephine M. I. Vos   +20 more
wiley   +1 more source

Toll‐Like Receptor Polymorphisms Influence Graft‐Versus‐Host Disease and Infection Risk After Single‐Unit Cord Blood Transplantation for Adults

European Journal of Haematology, EarlyView.
ABSTRACT Background Toll‐like receptors (TLRs) play a critical role in innate immunity by recognizing pathogen‐associated and damage‐associated molecular patterns. Genetic polymorphisms in TLR genes can modulate immune responses and have been implicated in the outcomes of allogeneic hematopoietic cell transplantation (HCT).
Takaaki Konuma, Megumi Hamatani‐Asakura, Seiko Kato, Shohei Andoh, Hirona Ichimura, Junichi Kuroda, Kaori Kondo, Kazuaki Yokoyama, Maki Monna‐Oiwa, Yasuhito Nannya, Satoshi Takahashi   +10 more
wiley   +1 more source

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Blood, 2015
D. Steensma, R. Bejar, S. Jaiswal, R. C. Lindsley, M. Sekeres, R. Hasserjian, B. Ebert   +6 more
semanticscholar   +1 more source

Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post‐revumenib therapies

British Journal of Haematology, EarlyView.
Miles Thomas, Hannah Johnston, Emily Dworkin, Austin Wesevich, Gregory W. Roloff, Caner Saygin, Mariam T. Nawas, Michael W. Drazer, Adam S. DuVall, Satyajit Kosuri, Michael J. Thirman, Olatoyosi Odenike, Wendy Stock, Richard A. Larson, Rafael Madero‐Marroquin, Anand A. Patel   +15 more
wiley   +1 more source

Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents

European Journal of Haematology, EarlyView.
ABSTRACT Acute myeloid leukemia (AML) in elderly patients presents a major therapeutic challenge, as many are deemed unfit for intensive chemotherapy due to age, comorbidities, or frailty. Venetoclax in combination with hypomethylating agents (HMA) has emerged as a standard‐of‐care for this population, yet outcomes remain heterogeneous and predictive ...
Ernesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, Andrea Corsonello, Santino Caserta, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Nicola Amodio, Fortunato Morabito, Massimo Gentile   +11 more
wiley   +1 more source

Biologic characteristics of acute leukemia after myelodysplastic syndrome [PDF]

, 1993
Masahiro Masuya, Kouji Kita, N. Shimizu, K Ohishi, Naoto Katayama, Takao Sekine, A Otsuji, H Miwa, S Shirakawa   +8 more
openalex   +1 more source

The PNH French Working Group Experience: Building a Strong Network of Cytometrists

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The PNH working group was created in 2010 to initiate a workshop on testing white blood cells to share international recommendations. Methods Thirty‐five French and Belgian laboratories equipped with 2‐ or 3‐laser cytometers applied three different panels with or without FLAER reagent in 305 samples.
Orianne Wagner‐Ballon, Magali Le Garff‐Tavernier, Rémi Lestestu, Bernard Drenou, Agathe Debliquis, the PNH French Working Group «CytHem‐HPN», Chantal Fossat, Claire Loosen, Bernard Chatelain, Marie Loosveld   +9 more
wiley   +1 more source

Hematopathology Practice in the Digital Era: What has Changed?

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematopathology workflows are complex, since they include numerous data points necessary for guiding further testing, diagnosis, and patient management. The workflows start with complete blood cell counts, with subsequent morphologic evaluation of peripheral blood (PB) and bone marrow (BM).
Olga Pozdnyakova
wiley   +1 more source